Despite high success rate in treating human Strongyloides infection with ivermectin, there is no consensus about the treatment of hyperinfection by helminths of the genus Strongyloides in immunocompromised people. Chances of survival of patients suffering from strongyloidiasis hyperinfection near 50%, with the toxicity of ivermectin in nervous system aggravating the puzzle. Creation of computer models capable of faithfully reproduce established knowledge about Strongyloides infection may be useful to understand the dynamics of infection and possible treatment. A computer model was developed in COPASI using ordinary differential equations representing dynamics of helminth life cycle in a hyperinfection. A combination of Boolean variables representing an 'immunosuppressed' host and 'treated' with four doses of ivermectin (200 µkg −1 ) raises four scenarios for time course simulations. Humoral and cellular immune responses were modeled using previous experiments whose data were approximated by ordinary functions. Three experiments, associated to strongyloidiasis hyperinfection, were successfully reproduced. A fourth scenario (immunosuppressed ∧ treated) yielded similar results compared to literature: four doses of ivermectin (200 µkg −1 ) were sufficient to restrain an infection, without a need for prolonged treatment. However, the smallest dosage does not suffice. A computational model for Strongyloides infection is available in SBML file format. The computational model here proposed for simulation of a hyperinfection by Strongyloides achieved similar results to previous experiments with hosts. It could allow us an in silico understanding of several aspects of infections caused by parasites of the genus Strongyloides.
INTRODUCTION
1 two species during infection is that in S. venezuelensis eggs shed through feces but S. stercoralis larvae (Yasuda et al., should be made as quickly as possible to allow preventing the disease development to dissemination and hyperinfection.
48
There are three methods of diagnosis: parasitologic, molecular and immunological (Levenhagen and Costa-Cruz, 2014). 
55
These drugs can present some toxicity for a patient organism, and some can lead to the development of larvae resistance. In these case, there is often the death of this patient, even when applying treatments that had healing success or survival 
COPASI tool

86
In this study, COPASI was used to create the model, quantity estimation of kinetic parameters, the initial concentration of 
Scenarios
93
Scenarios here explored considered as the start point the existence of just one adult worm with full reproductive capability.
94
A combination of variables health (immunocompromised or immunocompetent) and treatment (ivermectin use or not)
95 expressed the differences between scenarios according to the However, these can be found in the published SBML model (Additional file 1) 
Scenario S3 -immunosuppressed and untreated host 176
In Figure 4 is shown the simulation result of scenario S3. Similarly to S1, the infection spreading is fast, reaching a peak 
Scenario S4 -immunosuppressed and treated host 183
In Figure 5 , we verified scenarios S2 and S3 concomitantly. We considered an initial load of 100 adult worms. In Panel (Table 1) . In the proposed model from this study, the capacity to restrain 202 an infection is more robust for larvae than eggs. Adversely, in the case of larvae contention by the immune system, HR lead greater larvae exposure to the immune system and consequently enhancing facility to their identification. In this study,
210
we use referenced data coming from the S. venezuelensis species, which it is known commonly for expelling more eggs 211 than larvae through host feces. The eggs expelling assumption instead larvae could lead to the conclusion of reproducing 212 similarities between S. venezuelensis and S. stercoralis. 
Experiment simulation and prognosis
228
In this study, data from the literature were used to test the model proposed here for scenarios S1-S3, but there were not Blaxter, M. L., De Ley, P., Garey, J. R., Liu, L. X., Scheldeman, P., Vierstraete, A., Vanfleteren, J. R., Mackey, L. Y.,
